Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like FDA Hails Novartis' Kisqali a Breakthrough January 2, 2018 Teva Backpedals on 6,000 Job Cuts, Says Figure is Too High March 22, 2017 Some Predict Biogen???s Alzheimer???s Drug Will Fail April 25, 2017